ערבה 10 מג
sanofi israel ltd - leflunomide - טבליות מצופות פילם - leflunomide 10 mg - leflunomide - leflunomide - arava is indicated in adults for the treatment of active rheumatoid arthritis (ra) : 1. to reduce signs and symptoms 2. to inhibit structural damage as evidenced by x-ray erosions and joint space narrowing 3. to imptove physical function. arava is indicated for the treatment of adult patients with active psoriatic arthritis.
ערבה 20 מג
sanofi israel ltd - leflunomide - טבליות מצופות פילם - leflunomide 20 mg - leflunomide - leflunomide - arava is indicated in adults for the treatment of active rheumatoid arthritis (ra) : 1. to reduce signs and symptoms 2. to inhibit structural damage as evidenced by x-ray erosions and joint space narrowing 3. to imptove physical function. arava is indicated for the treatment of adult patients with active psoriatic arthritis.
טריפלונומיד טבע
teva israel ltd - teriflunomide - טבליות מצופות פילם - teriflunomide 14 mg - teriflunomide
טריפלונומיד מדומי
medomie pharma ltd, israel - teriflunomide - טבליות מצופות פילם - teriflunomide 14 mg - teriflunomide
טריפלונומיד תרו
taro international ltd, israel - teriflunomide - טבליות מצופות פילם - teriflunomide 14 mg - teriflunomide
אובג'יו
sanofi israel ltd - teriflunomide - טבליות מצופות פילם - teriflunomide 14 mg - teriflunomide
ערבה 100 מ"ג
sanofi - aventis israel ltd - leflunomide 100 mg - film coated tablets - leflunomide - arava is indicated in adults for the treatment of active rheumatoid arthritis (ra) : 1. to reduce signs and symptoms 2. to inhibit structural damage as evidenced by x-ray erosions and joint space narrowing 3. to imptove physical function. arava is indicated for the treatment of adult patients with active psoriatic arthritis.
יומירה
abbvie biopharmaceuticals ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg / 1 ml - adalimumab
אידסיו
neopharm (israel)1996 ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab
אמג'ויטה
amgen europe b.v. - adalimumab - תמיסה להזרקה - adalimumab 50 mg / 1 ml - adalimumab